Hepatocellular Carcinoma Risk Prediction Model for the General Population: The Predictive Power of Transaminases

Abstract

Models with transaminase data were best able to predict hepatocellular carcinoma risk even among subjects with unknown or HBV- or HCV-negative infection status.